Skip to main content
SpringerLink
Log in

Fibrinolytics and Antifibrinolytics

  • Book
  • © 1978

Overview

Editors:
  1. F. Markwardt

    1. Institut für Pharmakologie und Toxikologie, Medizinische Akademie Erfurt, Erfurt, German Democratic Republic

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 46)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (15 chapters)

  1. Front Matter

    Pages I-XXI
    Download chapter PDF

  2. The Fibrinolytic Process

    1. Front Matter

      Pages 1-1
      Download chapter PDF

    2. Biochemistry of the Factors of the Fibrinolytic System

      • H. Landmann
      Pages 3-48

    3. Fibrinogen and Fibrin Formation

      • B. Blombäck
      Pages 49-79

    4. Fibrinogen and Fibrin Degradation Products

      • M. Kopeć, Z. S. Latallo
      Pages 81-105

    5. The Measurement of Fibrinolytic Activities

      • I. M. Nilsson, U. Hedner, M. Pandolfi
      Pages 107-134

  3. Activators of Fibrinolysis

    1. Front Matter

      Pages 135-135
      Download chapter PDF

    2. Biochemistry of Streptokinase

      • F. B. Taylor Jr., P. C. Comp
      Pages 137-149

    3. Pharmacology of Streptokinase

      • H.-P. Klöcking
      Pages 151-177

    4. Clinical Use of Streptokinase

      • G. Vogel
      Pages 179-207

    5. Urokinase

      • F. Duckert
      Pages 209-237

    6. Synthetic Fibrinolytic Agents Induction of Fibrinolytic Activity In Vitro

      • K. N. von Kaulla
      Pages 239-272

    7. Indirect Fibrinolytic Agents

      • P. C. Desnoyers
      Pages 273-314

  4. Fibrinolytically Active Enzymes

    1. Front Matter

      Pages 315-315
      Download chapter PDF

    2. Plasmin

      • K. C. Robbins
      Pages 317-336

    3. Fungal Proteases

      • W. H. E. Roschlau
      Pages 337-450

    4. Defibrinogenation with Thrombin-Like Snake Venom Enzymes

      • K. Stocker
      Pages 451-484

  5. Antifibrinolytics

    1. Front Matter

      Pages 485-485
      Download chapter PDF

    2. Naturally Occurring Inhibitors of Fibrinolysis

      • F. Markwardt
      Pages 487-509

    3. Synthetic Inhibitors of Fibrinolysis

      • F. Markwardt
      Pages 511-577
Back to top

Keywords

About this book

Disturbances of haemostasis and thromboembolic disorders still constitute a great problem in clinical practice. Increasing insight into the mechanism of blood coagula­ tion has led to more effective therapy and prophylaxis. Particularly, the understand­ ing of the biochemistry of fibrinolysis has provided possibilities for the pharma­ cological interference of these processes, which has resulted in effective haemostatic agents and useful antithrombotic ones. The development of antifibrinolytics for interfering with pathological fibrinolytic processes is nearly complete and has led to the development of drugs essential to the therapy of hyperfibrinolytic bleeding. The search for fibrinolytics for dissolving intravascular thrombi has led to highly effective compounds. This development is still under way and promising results are hoped. Spontaneous dissolution of blood clots is a phenomenon which was described a century ago. First investigations of this process assured that there is in the organism a system capable of removing the fibrin which is formed during blood coagulation after it has fulfilled its physiological function. This fibrinolytic system is specifically adapted to the degradation of insoluble fibrin into soluble degradation products. In the past 30 years, thorough investigation of this system has clarified the fibrinolytic process, its physiological role and its meaning as a pathogenetic principle. A good knowledge of these processes is required for an understanding of the effects and side effects of fibrinolytics and antifibrinolytics, which comprise the basis of methods for the detection of fibrinolytic processes in the organism and of the control of therapy with these drugs.

Editors and Affiliations

  • Institut für Pharmakologie und Toxikologie, Medizinische Akademie Erfurt, Erfurt, German Democratic Republic

    F. Markwardt

Bibliographic Information

  • Book Title: Fibrinolytics and Antifibrinolytics

  • Editors: F. Markwardt

  • Series Title: Handbook of Experimental Pharmacology

  • DOI: https://doi.org/10.1007/978-3-642-66863-0

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin · Heidelberg 1978

  • Softcover ISBN: 978-3-642-66865-4Published: 13 December 2011

  • eBook ISBN: 978-3-642-66863-0Published: 06 December 2012

  • Series ISSN: 0171-2004

  • Series E-ISSN: 1865-0325

  • Edition Number: 1

  • Number of Pages: XXII, 656

  • Topics: Medicine/Public Health, general, Pharmacy

Publish with us

Policies and ethics

Back to top

Search

Navigation